info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

US Conjugate Vaccines Market Research Report, By Type (Haemophilus B, Monovalent, Multivalent, And Others), Indication (Influenza, Pneumococcal, Meningococcal, And Others), End Users (Pediatrics And Adults) - Forecast Till 2032


ID: MRFR/Pharma/11305-CR | 100 Pages | Author: Garvit Vyas| December 2023

The demand for conjugate vaccines in the United States has been steadily increasing in recent years, driven by several factors. Conjugate vaccines are crucial in preventing infectious diseases by stimulating the immune system to produce antibodies against specific pathogens. One of the primary drivers of demand is the growing awareness and concern about vaccine-preventable diseases among both healthcare professionals and the general public. With the rise of social media and increased access to information, more people are becoming aware of the importance of vaccination in protecting against serious illnesses.


Furthermore, the introduction of new conjugate vaccines targeting a variety of diseases has expanded the market significantly. Diseases such as pneumococcal infections, meningitis, and Haemophilus influenzae type b (Hib) are now preventable through the use of conjugate vaccines. As a result, healthcare providers are increasingly recommending these vaccines for both children and adults, contributing to the rising demand.


Government initiatives and vaccination programs have also played a significant role in driving demand for conjugate vaccines. The Centers for Disease Control and Prevention (CDC) and other public health agencies actively promote vaccination as a key strategy in preventing the spread of infectious diseases. These agencies often provide funding, resources, and guidelines to support vaccination efforts across the country, further increasing the accessibility and demand for conjugate vaccines.


In addition to the public sector, the private sector also plays a crucial role in driving demand for conjugate vaccines in the United States. Pharmaceutical companies invest heavily in research and development to create new and improved vaccines that target a wider range of diseases. The availability of these vaccines in the market gives healthcare providers more options to protect their patients, leading to increased demand.


The COVID-19 pandemic has further highlighted the importance of vaccination and immunization efforts. The rapid development and distribution of COVID-19 vaccines have demonstrated the power of vaccination in controlling and preventing infectious diseases. This increased focus on vaccination has spilled over into other vaccine-preventable diseases, including those targeted by conjugate vaccines.


Moreover, changes in healthcare policies and insurance coverage have also influenced the demand for conjugate vaccines. Many insurance plans now cover the cost of vaccinations, making them more accessible to a broader population. Additionally, initiatives such as the Vaccines for Children (VFC) program ensure that children from low-income families have access to necessary vaccinations, including conjugate vaccines, further boosting demand.


The aging population in the United States is another factor contributing to the demand for conjugate vaccines. As people age, their immune systems weaken, making them more susceptible to infectious diseases. Healthcare providers often recommend vaccines such as the pneumococcal conjugate vaccine (PCV13) and the herpes zoster vaccine to protect older adults against illnesses that can have severe consequences.

Report Attribute/Metric Details
  Market Size   USD 6.80 Billion
  CAGR   7.3%
  Base Year   2021
  Forecast Period   2023-2032
  Historical Data   2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Vaccine, Serotype, End User and Region
  Geographies Covered   North America, Europe, Asia Pacific, and Rest of the World
  Key Vendors   Pfizer Inc (US), Novartis AG (Switzerland), Sanofi S.A.(France), Serum Institute of India Pvt. Ltd (India), GlaxoSmithKline plc (UK), Merck & Co., Inc (US), Incepta Pharmaceuticals Ltd (Bangladesh), BIO-MED (US), Walvax Biotechnology Co., Ltd (China), Bio-Manguinhos (Brazil)
  Key Market Opportunities   Increasing inclusion in national immunization programs
  Key Market Drivers   Increasing awareness and surge in travel vaccine Increase in R&D for vaccine technology


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.